The increased sclerostin serum levels observed in CKD could be caused by several factors including sclerostin renal retention, even if it has been reported that urinary sclerostin excretion rises with declining eGFR, but also with an enhanced production by bone cells [40,41]. Here, SOST is linked to chronic kidney disease.